Biogen, UPMC Health Plan Contract Links PROs to Drug Reimbursement for Multiple Sclerosis
Biogen and UPMC Health Plan have signed off on a value-based contract that would link reimbursement to patient-reported outcomes for [...]
IQWiG: Patient Registry Data can be Used in Benefit Assessments
High-quality data from patient registries can be utilized for added benefit assessments for new drugs, the Institute for Quality and [...]
Pink Sheet Report Looks at Influence of NHS England, NICE
A recent analysis by The Pink Sheet dives into the influence of two drug pricing forces in the U.K.: the [...]
Survey Finds Increasing Interest in Patient-Reported Data from Outcomes-Based Contracts
A new survey conducted by Avalere Health suggests rising interest among payers to generate patient-reported data through outcomes-based contracts, according [...]
Report: Gene Therapies Could Add $45B to Health Costs
A new report from CVS Health suggests gene therapies could add an additional $45 billion to health care costs over [...]
ISPOR Conducting Survey on Current Understanding of COA Terms
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Clinical Outcome Assessment (COA) Special Interest Group is seeking member input [...]
FDA Pushes Back Deadline for Feedback on Drug Effectiveness Evidence Guide
The Food and Drug Administration (FDA) announced last week that it had extended the deadline for input on its draft [...]
GMI: HEOR Market to Hit $1.7B by 2026
The health economics and outcomes research (HEOR) market will exceed $1.7 billion by 2026, Global Market Insights suggests in a [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
SDOH Vendors Look to Build Pathways to Key Resources
New specialized vendors are taking action with social determinants of health by developing new software solutions that aim to bridge [...]
Dems Pivot to Insulin, Illinois Caps Insulin Prices
Democratic presidential candidates during a campaign stop in Iowa made clear their frustration over U.S. insulin prices, STAT reports. During [...]
NPC’s Leonard Outlines ‘Wish List’ for Health Sector
National Pharmaceutical Council President and CEO Dan Leonard in an article published on Chain Drug Review outlines his wish list [...]
Epic Chief Urges Hospital CEOs Oppose Proposal
Epic CEO Judy Faulkner in an email sent to hospital CEOs and presidents urged recipients to rally behind the medical [...]
Systematic Review Experts Offer Tips for Full-Text Reference Retrieval
A recent Evidence Partners blog post features key tips for full-text reference procurement from two systematic review experts. The author, [...]
ICER Outlines Planned Review of Hemophilia A Treatments
The Institute for Clinical and Economic Review (ICER) released a draft scoping document outlining its planned review of two treatments [...]
Blog Post Highlights AMCP’s Partnership Forum
A recent National Pharmaceutical Council (NPC) blog post highlights the Academy of Managed Care Pharmacy (AMCP) Partnership Forum, "Optimizing Prior [...]
Supreme Court to Hear Lawsuit Challenging State’s Authority to Regulate PBMs
The Supreme Court is set to hear a lawsuit filed by the Pharmaceutical Care Management Association which challenges an Arkansas [...]
Value in Health Publishes Themed Section on HTA
Value in Health announced the publication of a series of articles that delve into how health technology assessment (HTA) is [...]
Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]
Report: Pharma Spent $120M on Lobbying Last Year
New federal disclosures revealed that 34 major pharmaceutical companies spent more than $120 million on lobbying last year, STAT reports. [...]
ICER Posts Draft Report on Sickle Cell Disease Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 23, released a draft evidence report assessing treatments for [...]
Precision Xtract Launches ‘First-of-its-Kind’ Translation Service
Precision Xtract this week announced the launch of an innovative subscription-based translation service which gives clients the power to unmask [...]
JMCP Welcomes Prominent Researchers to Editorial Team
The Journal of Managed Care & Specialty Pharmacy (JMCP) is welcoming two prominent health care researchers to its editorial team [...]
The Importance of Collaboration in Value-Based Deals
A recent blog post on LillyPad, the official blog of Eli Lilly and Company, highlights the importance of ensuring collaboration [...]
Page Talks Patient-Centered Pathways, RWE, AI
Center for Cancer and Blood Disorders President and Director of Research Ray Page in a recent podcast posted on the [...]